Phoenix Biotech Acquisition (Phoenix Biotech Acquisition) EV-to-EBITDA : -9.80 (As of May. 30, 2024)

Phoenix Biotech Acquisition EV-to-EBITDA Chart

Phoenix Biotech Acquisition Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EV-to-EBITDA	Get a 7-Day Free Trial					-118.59	-23.99	-23.54	-17.58	-17.95

Competitive Comparison of Phoenix Biotech Acquisition's EV-to-EBITDA

For the Shell Companies subindustry, Phoenix Biotech Acquisition's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phoenix Biotech Acquisition's EV-to-EBITDA Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Phoenix Biotech Acquisition's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Phoenix Biotech Acquisition's EV-to-EBITDA falls into.

Phoenix Biotech Acquisition EV-to-EBITDA Calculation

Phoenix Biotech Acquisition's EV-to-EBITDA for today is calculated as:

Phoenix Biotech Acquisition's current Enterprise Value is $37.75 Mil.
Phoenix Biotech Acquisition's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.85 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phoenix Biotech Acquisition  (NAS:PBAX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Phoenix Biotech Acquisition's PE Ratio for today is calculated as:

Phoenix Biotech Acquisition's share price for today is $5.85.
Phoenix Biotech Acquisition's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.340.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Phoenix Biotech Acquisition EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Phoenix Biotech Acquisition's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Phoenix Biotech Acquisition (Phoenix Biotech Acquisition) Business Description